ENTITY
Glenmark Pharmaceuticals

Glenmark Pharmaceuticals (GNP IN)

133
Analysis
Health CareIndia
Glenmark Pharmaceuticals Ltd., is a pharmaceutical company. The Company develops generic drugs for inflammation, metabolic disorders, and pain.
more
Refresh
18 Feb 2019 00:00

Glenmark - Earnings Flash - Q3 FY 2018-19 Results - Lucror Analytics

Glenmark’s Q3/18-19 results very much surprised on the upside, with strong revenue and earnings growth after a few weak quarters. This was thanks...

Logo
55 Views
Share
04 Feb 2019 00:00

Asia HY Monthly - Agency Ratings For Asian Issuers - Lucror Analytics

In this month’s “In-Focus” section, we look at agency ratings for Asian issuers. The Asia Monthly focuses on providing updates on recent events,...

Logo
70 Views
Share
25 Jan 2019 00:00

Asia HY Trade Recommendations - January 2019 - Lucror Analytics

The Asia HY Trade Recommendations report for January includes a summary of our recommendations, as well as our high-conviction ideas. We also...

Logo
44 Views
Share
01 Jan 2019 22:29

India Generic Drugs: Antitrust Suit Could Cost Billions

This Insight builds on our previous Insight, India Generic Drugs: US Antitrust Inquiry Widens by discussing estimated potential liabilities and...

Share
15 Nov 2018 21:39

Global Markets Outlook: Maintain Defensive Posture

Our outlook for global equity markets remains cautious and we expect additional weakness and consolidation, notwithstanding shorter-term...

Logo
541 Views
Share
x